Improved Sanofi HIV test approved in US:
This article was originally published in Clinica
Executive Summary
Sanofi Diagnostics Pasteur has received FDA approval for a more sensitive and specific version of its HIV-1/HIV-2 Peptide enzyme immunoassay. The broad reactivity of the test is achieved by combining the most immunodominant synthetic peptide epitopes derived from the env and pol gene products for both HIV-1 and HIV-2, according to the company. Sanofi's US subsidiary, Genetic Systems, developed the new test and is marketing the product to US blood banks and other institutions.